NOIDA, India: Jubilant Life Sciences Ltd (formerly Jubilant Organosys Ltd) an integrated Pharma and Life Sciences company and the largest Custom Research & Manufacturing player out of India, announced today that it is setting up a manufacturing plant for "2,3,5,6-Tetra Chloro Pyridine" (also commercially known as Symtet/TCP) of 24,000 TPA capacity and Chlorinated Pyridine derivatives of 5,000 TPA,in Special Economic Zone, at Bharuch, Gujrat.

Symtet is used in the manufacturing of Chlorpyrifos, one of the world's largest and safest, low cost Insecticide, having a growth of ~ 7% globally. This facility is expected to be operational from Q4 FY2012 and will make Jubilant the largest producer of Symtet globally, catering to more than 40% of the worldwide demand.

The Company has received approvals from major customers and is in the process of firming up long term arrangements with them. It expects to achieve additional annual revenue of ~ US$ 90 Million from this facility.

Jubilant has developed this niche technology using Pyridine, its captive raw material, for manufacturing Symtet through much cleaner and environment friendly process compared to the alternate route using 'Trichloro Acetyl Chloride' (TCAC).

Commenting on the development, Mr. Shyam S Bhartia, Chairman & Managing Director and Mr. Hari S Bhartia, Co-Chairman & Managing Director, Jubilant Life Sciences Ltd, said, "Jubilant will be the only company in the world manufacturing Symtet through this environment friendly technology, developed by inhouse R&D having complete backward integration upto the basic feed stock. Through this technology Jubilant has identified additional use of Pyridine. It will provide an innovative solution to its customers by providing a penultimate intermediate using single step chemistry leading to a better quality agrochemical product with higher yield."

About Jubilant

Jubilant Life Sciences Limited (formerly Jubilant Organosys Ltd) is an integrated Pharma and Life Sciences Company. It is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution (DDDS) provider out of India. The Company provides Life Sciences products and services across the value chain. With 10 world-class manufacturing facilities and a team of ~ 5700 multicultural people across the globe, the Company is committed to deliver value to its customers spread across 60 countries. The Company is well recognized as a 'Partner of Choice' by leading life sciences companies worldwide. For more info: http://www.jubl.com

For more information please contact:

Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential product characteristics and uses, product sales potential and target dates for product launch are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. Jubilant Life Sciences may, from time to time, make additional written and oral forward looking statements, including statements contained in the company's filings with the regulatory bodies and its reports to shareholders. The company assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

Jubilant Life Sciences Ltd - A Jubilant Bhartia Company

1 A Sector 16 A, Noida-201301, UP India, Tel: +91-120 2516601-11, http://www.jubl.com

    
    For Business:
    Rajesh Srivastava
    Jubilant Life Sciences Limited
    Ph: +91-120-4361201
    Email:rajesh_srivastava@jubl.com

    For Investors
    Nidhi Aggarwal
    Jubilant Life Sciences Limited
    Ph: +91-120-4361002
    E-mail: nidhi_aggarwal@jubl.com

    For Media
    Seema Ahuja
    Jubilant Life Sciences Limited
    Ph: +91-120-4361062
    E-mail: seema_ahuja@jubl.com